Pharmafile Logo
Pharmafocus logo
Advanced Search

MS

Showing 15 posts of 92 posts found.

Sanofi moves teriflunomide into phase III MS trials

October 26, 2010
Research and Development MS, Sanofi, Sanofi-Aventis, TERACLES, multiple sclerosis, relapsing multiple sclerosis, teriflunomide

Sanofi-Aventis is to begin the first phase III study of an oral drug as an add-on to standard therapy in …

News

Gilenya approved in Russia, awaits FDA decision

September 16, 2010
Sales and Marketing Cladribine, Gilena, MS

Novartis has won approval for its MS drug Gilenya in Russia but still awaits the FDA’s decision on its fate …

News

Cohn & Wolfe wins MS account

August 20, 2010
Medical Communications Cohn & Wolfe, Genzyme, MS

Cohn & Wolfe has won a global account with Genzyme to handle communications for its work with alemtuzumab in multiple …

News

Merck KGaA’s oral MS therapy gains US priority review

July 29, 2010
Sales and Marketing Cladribine, MS, Merck KGaA

Merck’s cladribine has been granted a priority review status by the FDA in a move that could see it come …

News

First oral MS treatment approved in Russia

July 12, 2010
Sales and Marketing Cladribine, MS, Merck Serono, Movectro

Regulators in Russia have approved Merck Serono’s cladribine, lining up the drug to be the first oral treatment for multiple …

News

Gilenia on track to become first oral MS drug

June 11, 2010
Sales and Marketing Gilenia, MS

Novartis’ oral MS therapy Gilenia has been boosted by an FDA committee’s unanimous recommendation for its approval. The drug is …

News

Merck Serono resubmits oral MS therapy to FDA

June 8, 2010
Research and Development Cladribine, MS, Merck KGaA

Merck Serono has re-submitted its oral multiple sclerosis therapy cladribine to US regulators. Merck Serono, a Swiss division of Merck …

News

Global MS awareness campaign launched

June 1, 2010
Medical Communications MS, Merck Serono

Merck Serono has launched a short film competition as part of a global campaign, Real MS, to raise awareness of …

News

Evotec wins grant to advance H3 receptor antagonist

May 4, 2010
Research and Development CNS, Evotec, MS

Evotec is to receive funding of up to 1.5 million euros from a German government fund to advance its H3 …

News

Trial boost for Merck KGaA’s cladribine

April 19, 2010
Research and Development Cladribine, MS, Merck KGaA, Merck Serono

New data from German pharma company Merck suggests its oral multiple sclerosis treatment cladribine has been successful in treating relapsing …

News

Gilenia cuts relapse rates in MS patients

April 14, 2010
Sales and Marketing Gilena, MS, Novartis

Novartis’ new oral multiple sclerosis treatment Gilenia has been shown to reduce relapse rates significantly in new trial data.Data presented …

News
Brain picture

Novartis gains edge in MS treatment race

February 22, 2010
Research and Development, Sales and Marketing Cladribine, Gilenia, MS, Novartis

Novartis’ new oral multiple sclerosis treatment Gilenia will be given a priority review by the FDA.This could lead to a …

News
Merck Serono

Cladribine still set to be first oral MS treatment

January 18, 2010
Sales and Marketing Cladribine, FTY-720, MS, Merck Serono

Merck Serono’s new oral treatment for multiple sclerosis cladribine is still tipped to reach the market ahead of its rival, …

News

Biogen submits Fampridine PR to European regulators

January 14, 2010
Sales and Marketing Biogen, Fampridine, MS

Biogen Idec is seeking European approval for a drug which helps multiple sclerosis sufferers to walk better. A marketing authorisation …

News

Novartis’ Extavia approved in US

August 19, 2009
Research and Development, Sales and Marketing Extavia, MS, Novartis

 Novartis has received US approval for its betaferon product for multiple sclerosis.Extavia’s active ingredient is interferon beta-1b, putting it into …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025